Bruker Corp. buy Guggenheim
Start price
24.02.25
/
50%
€50.02
Target price
24.02.26
-
Performance (%)
-33.15%
End price
25.02.26
€33.44
Summary
This prediction ended on 25.02.26 with a price of €33.44. The BUY prediction by Guggenheim for Bruker Corp. performed very badly with a performance of -33.15%. Guggenheim has a follow-up prediction for Bruker Corp. where he still thinks Bruker Corp. is a Buy. Dividends of €0.20 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bruker Corp. | 1.490% | 1.490% | -25.241% |
| iShares Core DAX® | -1,31 % | -0,78 % | 9,15 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % | 6,57 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % | 31,58 % |
| iShares S&P 500 | 1,42 % | -0,48 % | 3,62 % |
Comments by Guggenheim for this prediction
In the thread Bruker Corp. diskutieren
Bruker Co. (NASDAQ: BRKR) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for BRKR provided by MarketBeat
In the thread Trading Bruker Corp.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten